EGF-R POSITIVE NON-SMALL CELL LUNG CANCER
Clinical trials for EGF-R POSITIVE NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new EGF-R POSITIVE NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for EGF-R POSITIVE NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare lung cancer mutations: targeted pill shows promise
Disease control OngoingThis study tests a daily pill called dacomitinib in 30 people with advanced lung cancer that has uncommon EGFR gene mutations. The goal is to see if the drug can shrink tumors or slow the disease. Participants take the drug until their cancer worsens or they no longer benefit, an…
Matched conditions: EGF-R POSITIVE NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
New pill targets tough cancers: hope for lung and brain tumor patients
Disease control OngoingThis study tests an experimental pill called BDTX-1535 for people with advanced non-small cell lung cancer or a type of brain tumor called glioblastoma. The drug targets specific genetic changes in the cancer cells. The goal is to see if it is safe and shrinks tumors. About 200 a…
Matched conditions: EGF-R POSITIVE NON-SMALL CELL LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Black Diamond Therapeutics, Inc. • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC